Provensis patents expiration

1. Varithena patents expiration

VARITHENA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7731986 PROVENSIS Therapeutic foam
Nov, 2024

(1 year, 1 month from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6846412 PROVENSIS Combination filter assembly
Jul, 2022

(1 year, 2 months ago)

US8122917 PROVENSIS Apparatus and method for dispensing foam
Sep, 2024

(11 months from now)

US7814943 PROVENSIS Apparatus and method for dispensing foam
Nov, 2027

(4 years from now)

US9480652 PROVENSIS Aerosol valve
May, 2032

(8 years from now)

Drugs and Companies using POLIDOCANOL ingredient

Market Authorisation Date: 25 November, 2013

Treatment: A method of generating an injectable foam of controlled density and bubble size; A method of intravenous injection using ultrasound guidance, administered via a single cannula into the lumen of the ta...


More Information on Dosage

VARITHENA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic